Lilly-partnered radiopharma startup Aktis Oncology raises $175M

Sep 30, 2024 · Sign up for the latest from Aktis Oncology. Email address: Leave this field empty if you're human: Contact Us

CouponFollow Extension

$175
OFF

Lilly-partnered Radiopharma Startup Aktis Oncology Raises $175M

4 weeks from now

Sep 30, 2024 · Sign up for the latest from Aktis Oncology. Email address: Leave this field empty if you're human: Contact Us

aktisoncology.com

$175
OFF

Aktis Raises $175M To Fuel Radiopharma Drug Development

4 weeks from now

Sep 30, 2024 · Sign up for the latest from Aktis Oncology. Email address: Leave this field empty if you're human: Contact Us

aktisoncology.com

$175
OFF

Radiopharma Start-up Aktis Raises $175 Million

4 weeks from now

Oct 14, 2024 · Aktis Oncology, a radiopharmaceutical firm that launched in 2021, has raised $175 million in a series B financing round co-led by RA Capital Management, RTW Investments, …

acs.org

$60
OFF

Lilly Collaborates With Aktis To Strengthen Radiopharma Portfolio

4 weeks from now

May 21, 2024 · Lilly collaborates with Aktis to strengthen radiopharma portfolio. Aktis will receive $60m in an upfront payment from Lilly, with the biotech eligible for up to $1.1bn in milestone …

pharmaceutical-technology.com

$175
OFF

Lilly-partnered Radiopharma Startup Aktis Oncology Raises $175M

4 weeks from now

Sep 30, 2024 · As other young radiopharmaceutical companies get acquired by drugmakers, Boston-based Aktis Oncology wants to become one of the field's next hot startups. On …

endpts.com

$1
OFF

Eli Lilly Inks Deal Worth Over $1.1B To Develop ... - Radiology Business

4 weeks from now

May 21, 2024 · Drugmaker Eli Lilly has inked a deal worth over $1 billion to develop new radiopharmaceuticals in concert with biotechnology firm Aktis Oncology. Under terms of the …

radiologybusiness.com

$60
OFF

AKTIS ONCOLOGY ENTERS INTO STRATEGIC COLLABORATION …

4 weeks from now

May 21, 2024 · Aktis to receive a $60 million upfront payment for the collaboration in addition to an equity investment by Lilly; Aktis also eligible for milestone payments of up to $1.1 billion …

yahoo.com

$60
OFF

Lilly Pays Aktis $60M To Further Dial Into Radiopharma Signal

4 weeks from now

May 21, 2024 · Eli Lilly is continuing to ride the radiopharma wave, paying Aktis Oncology $60 million upfront to work on therapeutic and diagnostic products against multiple targets. Lilly …

fiercebiotech.com

$175
OFF

Aktis Oncology Raises $175m To Advance Radiopharmaceutical …

4 weeks from now

Oct 1, 2024 · Pharmaceutical Technology

aktisoncology.com

FAQs about Lilly-partnered radiopharma startup Aktis Oncology raises $175M Coupon?

What is aktis oncology doing with Eli Lilly?

Aktis Oncology, a biotechnology company discovering and developing novel targeted radiopharmaceuticals to treat a broad range of solid tumors, today announced a multi-target discovery collaboration agreement with Eli Lilly and Company to generate anticancer radiopharmaceuticals using Aktis Oncology's novel miniprotein technology platform. ...

What is aktis oncology doing with $175 million?

JacobH via Getty Images Boston-based Aktis Oncology has raised $175 million in fresh funding to advance its pipeline of radiopharmaceutical medicines for cancer. The Series B round, announced by Aktis Monday, was led by RA Capital Management and co-led by RTW Investments and Janus Henderson Investors. ...

Will Lilly acquire aktis pharmaceuticals?

Under the terms of the agreement, Lilly will gain worldwide rights to develop targets for radiopharmaceuticals discovered by Aktis. However, the deal does not include Aktis’ current pipeline, which consists of seven programmes. ...

Does aktis have a strategic partnership with Eli Lilly & Company?

Aktis also has a strategic collaboration with Eli Lilly and Company to leverage its miniprotein platform to develop novel radioconjugates outside of Aktis’ proprietary pipeline. To learn more about Aktis Oncology, visit www.aktisoncology.com. ...

Why is aktis partnering with Lilly?

"Our strategic collaboration with Lilly leverages Aktis' unique miniprotein radiopharmaceutical platform capabilities to address novel targets, while delivering a safe and effective clinical profile," said Matthew Roden, Ph.D., President and Chief Executive Officer of Aktis Oncology. ...

How much will Lilly pay aktis?

Lilly will give Aktis $60m in an upfront payment, with the biotech also having access to $1.1bn in milestone-based payments and royalties on sales. Under the terms of the agreement, Lilly will gain worldwide rights to develop targets for radiopharmaceuticals discovered by Aktis. ...